Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

In this focused text module, multidisciplinary expert faculty discuss how treatment for CLL has evolved rapidly during the past 5 years and how this has affected clinical practice, with case studies used to illustrate current therapeutic paradigms.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: October 6, 2022 Expired: No longer available for credit

In this focused, case-based text module, expert faculty review key trial data and patient-specific factors important to selecting optimal frontline therapy for patients with CLL.

Nichole Fisher, RN, BSN Anthony Perissinotti, PharmD, BCOP Jennifer Woyach, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: April 19, 2022 Expired: No longer available for credit

In this focused text module, a pharmacist, nurse, and leading CLL patient advocate and healthcare professional discuss common issues of concern for patients who have been diagnosed with CLL and best practices in patient education.

Nichole Fisher, RN, BSN Brian Koffman, MDCM (retired), MS Ed Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 17, 2022 Expired: No longer available for credit

In this focused text module, expert faculty discuss the latest information on measurable residual disease testing and clinical use in the care of patients with CLL.

Nichole Fisher, RN, BSN Anthony Perissinotti, PharmD, BCOP Jennifer Woyach, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: August 30, 2022 Expired: No longer available for credit

In this focused, case-based text module, multidisciplinary expert faculty review best practices in identifying and managing key adverse events commonly associated with BCL-2 and PI3K inhibitors in patients with CLL.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: May 19, 2022 Expired: No longer available for credit

In this focused, case-based text module, multidisciplinary expert faculty review common CLL-related symptoms and best practices in identifying and managing key adverse events commonly associated with BTK inhibitors in patients with CLL.

Nichole Fisher, RN, BSN Nicole Lamanna, MD Anthony Perissinotti, PharmD, BCOP Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: May 31, 2022 Expired: No longer available for credit